Get Your Own Businessabc AI Visibility ID
Boost AI visibility, credibility, and discoverability
Karuna Therapeutics was founded in July 2015 to develop treatments based on its unique understanding of brain chemistry and biology. The company has raised over $60 million in venture capital to date, and has built a robust product pipeline, highlighted by its lead compound, KarXT, a novel, orally-active modulator of multiple muscarinic receptors for the treatment of schizophrenia and other CNS disorders.
